These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23368767)

  • 21. Diagnosis and clinical features of epidermolysis bullosa acquisita.
    Caux F
    Dermatol Clin; 2011 Jul; 29(3):485-91, x. PubMed ID: 21605816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
    Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
    J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
    Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
    J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita.
    Hirose M; Tiburzy B; Ishii N; Pipi E; Wende S; Rentz E; Nimmerjahn F; Zillikens D; Manz RA; Ludwig RJ; Kasperkiewicz M
    J Invest Dermatol; 2015 Mar; 135(3):768-775. PubMed ID: 25330299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa acquisita in childhood.
    Callot-Mellot C; Bodemer C; Caux F; Bourgault-Villada I; Fraitag S; Goudié G; Heller M; de Prost Y; Prost C
    Arch Dermatol; 1997 Sep; 133(9):1122-6. PubMed ID: 9301589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita.
    Becker M; Schumacher N; Schmidt E; Zillikens D; Sadik CD
    JAMA Dermatol; 2021 Aug; 157(8):917-923. PubMed ID: 34160564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
    Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs.
    Stewart MI; Woodley DT; Briggaman RA
    Arch Dermatol; 1991 Mar; 127(3):373-7. PubMed ID: 1998368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
    Campos M; Silvente C; Lecona M; Suárez R; Lázaro P
    Clin Exp Dermatol; 2006 Jan; 31(1):71-3. PubMed ID: 16309488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood epidermolysis bullosa acquisita: report of a Chinese case.
    Yang B; Wang C; Wang N; Pan F; Chen S; Zhou G; Yu M; Zhang F
    Pediatr Dermatol; 2012; 29(5):614-7. PubMed ID: 21966900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients.
    Barreiro-Capurro A; Mascaró-Galy JM; Iranzo P
    Actas Dermosifiliogr; 2013 Dec; 104(10):904-14. PubMed ID: 23895729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidermolysis bullosa acquisita of childhood].
    Bordier-Lamy F; Eschard C; Coste M; Ploton D; Durlach A; Tabary T; Bernard P
    Ann Dermatol Venereol; 2009; 136(6-7):513-7. PubMed ID: 19560612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature.
    Vodegel RM; de Jong MC; Pas HH; Jonkman MF
    J Am Acad Dermatol; 2002 Dec; 47(6):919-25. PubMed ID: 12451379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
    Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
    Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita.
    Schauer F; Nyström A; Kunz M; Hübner S; Scholl S; Athanasiou I; Alter S; Fischer J; Has C; Kiritsi D
    Front Immunol; 2022; 13():883967. PubMed ID: 35464429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
    Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University.
    Hashimoto T; Jin Z; Ishii N
    Expert Rev Clin Immunol; 2016 Aug; 12(8):895-902. PubMed ID: 27247994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.
    Iwata H; Vorobyev A; Koga H; Recke A; Zillikens D; Prost-Squarcioni C; Ishii N; Hashimoto T; Ludwig RJ
    Orphanet J Rare Dis; 2018 Sep; 13(1):153. PubMed ID: 30180870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.